Supplementary Data from Marked Activity of Irinotecan and Rapamycin Combination toward Colon Cancer Cells In vivo and In vitro Is Mediated through Cooperative Modulation of the Mammalian Target of Rapamycin/Hypoxia-Inducible Factor-1α Axis

Authors:
  • EPErwan Pencreach
    Erwan Pencreach
  • EGEric Guérin
    Eric Guérin
  • CNCéline Nicolet
    Céline Nicolet
  • ILIsabelle Lelong-Rebel
    Isabelle Lelong-Rebel
  • AVAnne-Claire Voegeli
    Anne-Claire Voegeli
  • POPierre Oudet
    Pierre Oudet
  • ALAnnette K. Larsen
    Annette K. Larsen
  • MGMarie-Pierre Gaub
    Marie-Pierre Gaub
  • DGDominique Guenot
    Dominique Guenot

Abstract
Supplementary Data from Marked Activity of Irinotecan and Rapamycin Combination toward Colon Cancer Cells In vivo and In vitro Is Mediated through Cooperative Modulation of the Mammalian Target of Rapamycin/Hypoxia-Inducible Factor-1α Axis